Research Options:

Week of Expected Pricing Withdrawn
Company Name PELOTON THERAPEUTICS INC
Proposed Ticker N/A
CUSIP N/A
Business Description A clinical stage biopharmaceutical company focused on translating novel scientific insights into first-in-class medicines for patients with cancer and other debilitating or life-threatening conditions.
Lead Underwriter Citigroup Global Markets Inc ,J.P. Morgan Securities LLC ,Jefferies LLC
Co-Managers N/A
Initial Shares 93,75,000
Revised Initial Shares N/A
Initial Price $15.00-$17.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.